| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.02T | 3.12T | 2.95T | 2.35T | 1.85T | 1.58T |
| Gross Profit | 2.05T | 2.17T | 2.01T | 1.60T | 1.29T | 989.30B |
| EBITDA | 1.01T | 804.43B | 1.65T | 635.04B | 488.90B | 280.08B |
| Net Income | 528.91B | 542.08B | 510.29B | 442.56B | 340.37B | 251.10B |
Balance Sheet | ||||||
| Total Assets | 26.69T | 29.14T | 26.42T | 23.64T | 19.58T | 17.53T |
| Cash, Cash Equivalents and Short-Term Investments | 1.97T | 2.65T | 2.38T | 1.90T | 1.64T | 2.14T |
| Total Debt | 2.15T | 2.20T | 2.04T | 2.01T | 1.84T | 1.59T |
| Total Liabilities | 23.23T | 25.35T | 23.13T | 20.94T | 17.37T | 15.65T |
| Stockholders Equity | 3.30T | 3.63T | 3.14T | 2.56T | 2.14T | 1.82T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 635.95B | 773.94B | 1.54T | 552.00B | 777.05B |
| Operating Cash Flow | 0.00 | 673.25B | 822.20B | 1.57T | 577.21B | 795.97B |
| Investing Cash Flow | 0.00 | -130.14B | -2.37T | -1.46T | -2.53T | -1.94T |
| Financing Cash Flow | 0.00 | -46.61B | 2.06T | 137.65B | 1.47T | 1.51T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $96.33B | 9.08 | 21.64% | 9.77% | 22.96% | 6.95% | |
73 Outperform | $95.35B | 14.67 | 15.75% | 0.85% | 1.39% | 0.34% | |
72 Outperform | $125.09B | 4.96 | 13.60% | 3.03% | 0.81% | 1.99% | |
71 Outperform | $89.03B | 12.15 | 11.98% | 3.11% | 3.51% | 21.52% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | $78.00B | 9.28 | 9.93% | 3.19% | -15.15% | 29.78% | |
57 Neutral | $104.07B | 10.79 | 9.73% | 2.31% | -8.02% | 22.45% |